{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:33:06Z","timestamp":1779928386118,"version":"3.53.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","award":["364218"],"award-info":[{"award-number":["364218"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health, Czech Republic","award":["16-28135A"],"award-info":[{"award-number":["16-28135A"]}]},{"name":"Motol University Hospital, Prague","award":["00064203"],"award-info":[{"award-number":["00064203"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.urolonc.2019.03.014","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T23:35:49Z","timestamp":1556235349000},"page":"503-509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["NK and T cells with a cytotoxic\/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-9534","authenticated-orcid":false,"given":"Zuzana","family":"Strizova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Taborska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Stakheev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Partlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Havlova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepan","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirina","family":"Bartunkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0143-8744","authenticated-orcid":false,"given":"Daniel","family":"Smrz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2019.03.014_bib0001","series-title":"SEER cancer statistics review, 1975-2015, National Cancer Institute. Bethesda, MD","year":"2018"},{"issue":"1","key":"10.1016\/j.urolonc.2019.03.014_bib0002","doi-asserted-by":"crossref","first-page":"15698","DOI":"10.1038\/s41598-017-15922-4","article-title":"Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries","volume":"7","author":"Wong","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.urolonc.2019.03.014_bib0003","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2019.03.014_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2019.03.014_bib0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejca.2017.06.030","article-title":"Addressing the best treatment for non-clear cell renal cell carcinoma: a meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies","volume":"83","author":"Ciccarese","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2019.03.014_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2019.03.014_bib0007","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","article-title":"Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma","volume":"183","author":"Leibovich","year":"2010","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2019.03.014_bib0008","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.urolonc.2019.03.014_bib0009","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.critrevonc.2015.08.007","article-title":"Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy","volume":"96","author":"Diamond","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.03.014_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0360-3016(95)02029-2","article-title":"A review of human cell radiosensitivity in vitro","volume":"34","author":"Deschavanne","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.urolonc.2019.03.014_bib0011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11523-016-0463-4","article-title":"Resistance to targeted therapies in renal cancer: the importance of changing the mechanism of action","volume":"12","author":"Duran","year":"2017","journal-title":"Targeted Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.03.014_bib0012","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/j.clgc.2016.08.022","article-title":"Survival of patients with advanced or metastatic renal cell carcinoma in routine practice differs from that in clinical trials-analyses from the German clinical RCC registry","volume":"15","author":"Marschner","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2019.03.014_bib0013","doi-asserted-by":"crossref","first-page":"e1069","DOI":"10.1016\/j.clgc.2017.07.017","article-title":"Five-year survival of patients with metastatic renal cell carcinoma in the Russian federation: results from the RENSUR5 registry","volume":"15","author":"Tsimafeyeu","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"6230","key":"10.1016\/j.urolonc.2019.03.014_bib0014","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.urolonc.2019.03.014_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2217\/imt-2016-0112","article-title":"Adoptive cell therapy: past, present and future","volume":"9","author":"Cohen","year":"2017","journal-title":"Immunotherapy"},{"issue":"4","key":"10.1016\/j.urolonc.2019.03.014_bib0016","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4111\/icu.2017.58.4.220","article-title":"Novel immunotherapy in metastatic renal cell carcinoma","volume":"58","author":"Cho","year":"2017","journal-title":"Invest Clin Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.03.014_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020340","article-title":"Incorporation of immune checkpoint blockade into chimeric antigen receptor T cells (CAR-Ts): combination or built-in CAR-T","volume":"19","author":"Yoon","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.urolonc.2019.03.014_bib0018","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/14712598.2018.1473368","article-title":"Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities","volume":"18","author":"Shum","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.urolonc.2019.03.014_bib0019","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.urology.2005.11.030","article-title":"In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and\/or interleukin-2 gene in human renal cell carcinoma","volume":"67","author":"Tian","year":"2006","journal-title":"Urology"},{"issue":"17","key":"10.1016\/j.urolonc.2019.03.014_bib0020","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-11-0303","article-title":"Cell surface delivery of TRAIL strongly augments the tumoricidal activity of T cells","volume":"17","author":"de Bruyn","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.urolonc.2019.03.014_bib0021","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/gut.2004.052696","article-title":"Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease","volume":"54","author":"Strater","year":"2005","journal-title":"Gut"},{"issue":"Pt 11","key":"10.1016\/j.urolonc.2019.03.014_bib0022","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1242\/jcs.124099","article-title":"An immunologist's guide to CD31 function in T-cells","volume":"126","author":"Marelli-Berg","year":"2013","journal-title":"J Cell Sci"},{"issue":"8","key":"10.1016\/j.urolonc.2019.03.014_bib0023","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.4049\/jimmunol.1201739","article-title":"CD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivo","volume":"189","author":"Ma","year":"2012","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.urolonc.2019.03.014_bib0024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.imlet.2013.05.010","article-title":"Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma","volume":"152","author":"Minarik","year":"2013","journal-title":"Immunol Lett"},{"issue":"12","key":"10.1016\/j.urolonc.2019.03.014_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"13","key":"10.1016\/j.urolonc.2019.03.014_bib0026","first-page":"5132","article-title":"Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.urolonc.2019.03.014_bib0027","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-11-1316","article-title":"Prognostic and predictive impact of intra- and peritumoral immune infiltrates","volume":"71","author":"Fridman","year":"2011","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.urolonc.2019.03.014_bib0028","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1158\/1078-0432.CCR-14-2926","article-title":"Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer","volume":"21","author":"Giraldo","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919301103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919301103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:14:56Z","timestamp":1761041696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919301103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1078143919301103"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.03.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK and T cells with a cytotoxic\/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}